{"gene":"SZT2","run_date":"2026-04-28T21:42:58","timeline":{"discoveries":[{"year":2017,"finding":"SZT2 recruits a fraction of mammalian GATOR1 and GATOR2 to form a SZT2-orchestrated GATOR (SOG) complex; the interaction of SZT2 with GATOR1 and GATOR2 is synergistic, and an intact SOG complex is required for lysosomal localization of the complex and GATOR/SESN-dependent nutrient sensing and mTORC1 regulation.","method":"Co-immunoprecipitation, lysosomal fractionation, genetic rescue experiments (DEPDC5 overexpression, lysosome-targeted WDR59/SESN2), mouse knockout model with neonatal lethality phenotype","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including Co-IP, fractionation, in vivo mouse KO, and genetic rescue; highly cited foundational study","pmids":["28199315"],"is_preprint":false},{"year":2017,"finding":"SZT2 deficiency results in constitutive mTORC1 signalling under nutrient-deprived conditions in cells, and failure to inactivate mTORC1 during fasting in vivo, demonstrating SZT2 is required for mTORC1 downregulation upon nutrient deprivation.","method":"Mouse knockout (neonatal lethality), cell-based mTORC1 activity assays under nutrient deprivation, genetic rescue with DEPDC5/GATOR2 components","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and in vivo phenotype, replicated in multiple experimental systems, highly cited","pmids":["28199315"],"is_preprint":false},{"year":2019,"finding":"Biallelic loss-of-function SZT2 mutations in patient-derived lymphoblastoid cell lines cause constitutive hyperactivation of mTORC1 (increased S6K and S6 phosphorylation) under amino acid starvation, and constitutive lysosomal localization of mTOR, confirming the loss-of-function mechanism in human patient cells.","method":"Patient-derived lymphoblastoid cell lines, phosphorylation assays (S6K, S6), immunofluorescence for lysosomal mTOR localization under amino acid starvation","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — two orthogonal methods (biochemical phosphorylation + lysosomal localization imaging) in patient-derived cells; single lab","pmids":["31430354"],"is_preprint":false},{"year":2021,"finding":"Systematic interactome analysis of SZT2 identified interaction partners including mTORC1 and AMPK signaling components, autophagy regulators (selective autophagy receptors), ciliogenesis regulators, and neurogenesis-related proteins; SZT2 KO cells show increased mTORC1 signaling (reversible by Rapamycin/Torin) and elevated autophagic components independent of physiological conditions.","method":"Mass spectrometry-based interactome analysis under catabolic and anabolic conditions, SZT2 KO cell lines with mTORC1 activity measurement, Rapamycin/Torin pharmacological rescue","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2-3 — MS interactome plus KO phenotype rescue; single lab but multiple orthogonal approaches","pmids":["34685691"],"is_preprint":false},{"year":2022,"finding":"SZT2 is required for hematopoietic stem cell (HSC) homeostasis via nutrient-mediated mTORC1 regulation; loss of SZT2 decreases HSC reserve and impairs repopulating capacity, and combined loss of SZT2 and TSC1 produces a synergistic ~10-fold increase in mTORC1 activity and ~100-fold increase in ROS, rapidly depleting HSCs.","method":"HSC-specific conditional KO mice, bone marrow transplantation repopulation assay, mTORC1 activity measurement, ROS quantification, double KO (SZT2 + TSC1) genetic epistasis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with defined cellular phenotype, genetic epistasis with TSC1, multiple orthogonal readouts in vivo","pmids":["36250465"],"is_preprint":false},{"year":2022,"finding":"A recurrent in-frame deletion SZT2 p.Val1984del is a loss-of-function variant in the mTORC1 signaling pathway, identified as a founder variant in individuals of Ashkenazi Jewish ancestry, using a functional mTORC1 assay to reclassify variants of uncertain significance.","method":"Cell-based mTORC1 functional assay for SZT2 variants, haplotype analysis for founder effect determination","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 — functional assay directly measuring mTORC1 activity for specific variant; single lab","pmids":["35773235"],"is_preprint":false},{"year":2026,"finding":"SZT2 dysfunction in human brain organoids causes overproduction of outer radial glial cells (oRGCs) in the SVZ-like layer and increased upper-layer neurons, through elevated mTORC1 activity in the SVZ, suggesting SZT2-mediated mTORC1 regulation controls cortical expansion and underlies macrocephaly.","method":"Patient-derived iPSC brain organoids, immunostaining for oRGC and neuron markers, mTORC1 activity measurement in SVZ region of organoids","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — human brain organoid model with cellular phenotype and mTORC1 mechanistic link; single lab, novel approach","pmids":["41535455"],"is_preprint":false},{"year":2018,"finding":"SZT2 variants in a patient with early-onset epileptic encephalopathy impair mitochondrial energy metabolism, providing evidence for a pathogenic molecular mechanism involving mitochondrial dysfunction.","method":"Case study with metabolic/mitochondrial functional analyses in patient cells","journal":"Clinical case reports","confidence":"Low","confidence_rationale":"Tier 3 — single patient case, single lab, limited mechanistic detail on how SZT2 affects mitochondrial function","pmids":["30564332"],"is_preprint":false}],"current_model":"SZT2 is a metazoan-specific scaffolding protein that assembles GATOR1, GATOR2, and SESN proteins into a SOG (SZT2-orchestrated GATOR) complex at the lysosome, where it functions as an essential upstream regulator of the amino acid-sensing branch of mTORC1 signaling by promoting lysosomal localization of GATOR complexes and enabling SESN-dependent GDI activity toward RAG GTPases, such that SZT2 loss causes constitutive mTORC1 hyperactivation under nutrient deprivation, with downstream consequences including impaired autophagy, excess outer radial glia production, and hematopoietic stem cell depletion."},"narrative":{"teleology":[{"year":2017,"claim":"Establishing how SZT2 connects to mTORC1 signaling resolved the question of its molecular function: SZT2 nucleates a SOG complex by synergistically binding GATOR1 and GATOR2, recruiting them to the lysosome where they mediate SESN-dependent nutrient sensing and mTORC1 inhibition upon amino acid deprivation.","evidence":"Co-immunoprecipitation, lysosomal fractionation, genetic rescue (DEPDC5 overexpression, lysosome-targeted WDR59/SESN2), and neonatal-lethal mouse KO","pmids":["28199315"],"confidence":"High","gaps":["Structural basis for SZT2's synergistic bridging of GATOR1 and GATOR2 is unknown","Whether SZT2 directly binds RAG GTPases or solely acts through GATOR/SESN remains unresolved","Lysosomal targeting determinants within SZT2 are not mapped"]},{"year":2018,"claim":"A case linking SZT2 variants to mitochondrial energy defects raised the question of whether SZT2 has mTORC1-independent roles in mitochondrial metabolism.","evidence":"Single patient case study with metabolic/mitochondrial functional analyses in patient cells","pmids":["30564332"],"confidence":"Low","gaps":["Single patient without independent replication or mechanistic dissection of how SZT2 affects mitochondria","Whether the mitochondrial phenotype is secondary to chronic mTORC1 hyperactivation is untested","No mitochondrial interaction partners of SZT2 are identified"]},{"year":2019,"claim":"Validation in human patient-derived cells confirmed that biallelic SZT2 loss-of-function mutations produce constitutive mTORC1 activity and mTOR mis-localization to lysosomes during amino acid starvation, translating the mouse findings to human disease.","evidence":"Patient-derived lymphoblastoid cell lines with phosphorylation assays (S6K, S6) and immunofluorescence for lysosomal mTOR","pmids":["31430354"],"confidence":"Medium","gaps":["Only lymphoblastoid cells examined; neuronal cell types not tested","Downstream consequences of constitutive mTORC1 in patient cells (e.g., autophagy, protein synthesis) not characterized"]},{"year":2021,"claim":"Systematic interactome mapping expanded the SZT2 interaction network beyond GATOR to include autophagy receptors and ciliogenesis regulators, and showed that SZT2 KO elevates autophagic components irrespective of metabolic state.","evidence":"Mass spectrometry-based interactome under catabolic and anabolic conditions; SZT2 KO cell lines with Rapamycin/Torin rescue","pmids":["34685691"],"confidence":"Medium","gaps":["Direct physical interactions with autophagy receptors and ciliogenesis regulators await reciprocal validation","Whether autophagy dysregulation is mTORC1-dependent or an independent SZT2 function is not resolved","Functional relevance of ciliogenesis interactors remains untested"]},{"year":2022,"claim":"Demonstrating that SZT2 loss depletes HSCs and synergizes with TSC1 loss to massively elevate mTORC1 and ROS established SZT2 as operating in a nutrient-sensing axis parallel to TSC for stem cell maintenance.","evidence":"HSC-specific conditional KO mice, bone marrow transplantation, genetic epistasis with TSC1 double KO, ROS quantification","pmids":["36250465"],"confidence":"High","gaps":["Whether mTORC1-independent mechanisms contribute to HSC depletion is unknown","ROS source (mitochondrial vs. other) upon SZT2/TSC1 double loss is not identified","Whether rapamycin rescues the HSC phenotype in vivo was not reported"]},{"year":2022,"claim":"Functional classification of a recurrent SZT2 founder variant (p.Val1984del) as loss-of-function in the mTORC1 pathway provided a direct genotype-to-mechanism link for clinical variant interpretation.","evidence":"Cell-based mTORC1 functional assay for SZT2 variants, haplotype analysis in Ashkenazi Jewish cohort","pmids":["35773235"],"confidence":"Medium","gaps":["Structural consequence of Val1984 deletion on SOG complex assembly is not characterized","Functional assay validated for limited number of variants"]},{"year":2026,"claim":"Brain organoid modeling revealed that SZT2 dysfunction drives overproduction of outer radial glia through elevated SVZ mTORC1, providing a cellular mechanism for the macrocephaly seen in patients.","evidence":"Patient-derived iPSC brain organoids with immunostaining for oRGC/neuron markers and regional mTORC1 activity measurement","pmids":["41535455"],"confidence":"Medium","gaps":["Whether mTORC1 inhibition rescues the oRGC phenotype in organoids was not shown","In vivo validation in animal models of cortical expansion is lacking","Cell-type-specific SZT2 expression in developing human cortex is not characterized"]},{"year":null,"claim":"The structural architecture of SZT2, its precise lysosomal targeting mechanism, and whether it has mTORC1-independent functions in autophagy, ciliogenesis, or mitochondrial metabolism remain open questions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural or cryo-EM model of SZT2 or the SOG complex exists","mTORC1-independent roles suggested by interactome data are functionally unvalidated","Tissue-specific requirements for SZT2 beyond brain and hematopoietic system are unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,4]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[3]}],"complexes":["SOG (SZT2-orchestrated GATOR) complex"],"partners":["DEPDC5","WDR59","SESN2","TSC1"],"other_free_text":[]},"mechanistic_narrative":"SZT2 is a large scaffolding protein that orchestrates amino acid sensing upstream of mTORC1 by assembling GATOR1, GATOR2, and SESN proteins into a lysosome-associated SOG (SZT2-orchestrated GATOR) complex, thereby enabling nutrient-dependent mTORC1 inactivation [PMID:28199315]. Loss of SZT2 causes constitutive mTORC1 hyperactivation under nutrient deprivation, leading to impaired hematopoietic stem cell homeostasis with depleted HSC reserves and synergistic ROS elevation when combined with TSC1 loss [PMID:36250465], and to excess outer radial glia production and cortical expansion in human brain organoids [PMID:41535455]. Biallelic loss-of-function mutations in SZT2, including a recurrent founder variant in Ashkenazi Jewish individuals, cause early-onset epileptic encephalopathy with macrocephaly [PMID:35773235, PMID:31430354]."},"prefetch_data":{"uniprot":{"accession":"Q5T011","full_name":"KICSTOR complex protein SZT2","aliases":["Seizure threshold 2 protein homolog"],"length_aa":3432,"mass_kda":378.0,"function":"As part of the KICSTOR complex functions in the amino acid-sensing branch of the TORC1 signaling pathway. Recruits, in an amino acid-independent manner, the GATOR1 complex to the lysosomal membranes and allows its interaction with GATOR2 and the RAG GTPases. Functions upstream of the RAG GTPases and is required to negatively regulate mTORC1 signaling in absence of amino acids. In absence of the KICSTOR complex mTORC1 is constitutively localized to the lysosome and activated. The KICSTOR complex is also probably involved in the regulation of mTORC1 by glucose (PubMed:28199306, PubMed:28199315). May play a role in the cellular response to oxidative stress (By similarity)","subcellular_location":"Lysosome membrane; Peroxisome","url":"https://www.uniprot.org/uniprotkb/Q5T011/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SZT2","classification":"Not Classified","n_dependent_lines":24,"n_total_lines":1208,"dependency_fraction":0.019867549668874173},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SZT2","total_profiled":1310},"omim":[{"mim_id":"621100","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 83; MRT83","url":"https://www.omim.org/entry/621100"},{"mim_id":"617421","title":"INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 2; ITFG2","url":"https://www.omim.org/entry/617421"},{"mim_id":"617420","title":"KICSTOR SUBUNIT 2; KICS2","url":"https://www.omim.org/entry/617420"},{"mim_id":"617418","title":"WD REPEAT-CONTAINING PROTEIN 59; WDR59","url":"https://www.omim.org/entry/617418"},{"mim_id":"615620","title":"KAPTIN; KPTN","url":"https://www.omim.org/entry/615620"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"},{"location":"Actin filaments","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SZT2"},"hgnc":{"alias_symbol":["FLJ10387","SZT2B","RP11-506B15.1","FLJ34502","SZT2A","KICS1"],"prev_symbol":["C1orf84","KIAA0467"]},"alphafold":{"accession":"Q5T011","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5T011","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5T011-7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5T011-7-F1-predicted_aligned_error_v6.png","plddt_mean":83.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SZT2","jax_strain_url":"https://www.jax.org/strain/search?query=SZT2"},"sequence":{"accession":"Q5T011","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5T011.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5T011/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5T011"}},"corpus_meta":[{"pmid":"28199315","id":"PMC_28199315","title":"SZT2 dictates GATOR control of mTORC1 signalling.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28199315","citation_count":158,"is_preprint":false},{"pmid":"23932106","id":"PMC_23932106","title":"Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum.","date":"2013","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23932106","citation_count":68,"is_preprint":false},{"pmid":"19624305","id":"PMC_19624305","title":"Szt2, a novel gene for seizure threshold in mice.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19624305","citation_count":49,"is_preprint":false},{"pmid":"27248490","id":"PMC_27248490","title":"Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants.","date":"2016","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/27248490","citation_count":27,"is_preprint":false},{"pmid":"28556953","id":"PMC_28556953","title":"Novel biallelic SZT2 mutations in 3 cases of early-onset epileptic encephalopathy.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28556953","citation_count":24,"is_preprint":false},{"pmid":"29696782","id":"PMC_29696782","title":"Mutations in SZT2 result in early-onset epileptic encephalopathy and leukoencephalopathy.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/29696782","citation_count":17,"is_preprint":false},{"pmid":"32402703","id":"PMC_32402703","title":"Developmental and epileptic encephalopathy due to SZT2 genomic variants: Emerging features of a syndromic condition.","date":"2020","source":"Epilepsy & behavior : E&B","url":"https://pubmed.ncbi.nlm.nih.gov/32402703","citation_count":16,"is_preprint":false},{"pmid":"30315519","id":"PMC_30315519","title":"A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy.","date":"2018","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30315519","citation_count":15,"is_preprint":false},{"pmid":"37213690","id":"PMC_37213690","title":"SZT2 variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation.","date":"2023","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37213690","citation_count":14,"is_preprint":false},{"pmid":"30818181","id":"PMC_30818181","title":"Compound heterozygous SZT2 mutations in two siblings with early-onset epilepsy, intellectual disability and macrocephaly.","date":"2018","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/30818181","citation_count":14,"is_preprint":false},{"pmid":"31430354","id":"PMC_31430354","title":"Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31430354","citation_count":13,"is_preprint":false},{"pmid":"31397114","id":"PMC_31397114","title":"Novel SZT2 mutations in three patients with developmental and epileptic encephalopathies.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31397114","citation_count":12,"is_preprint":false},{"pmid":"30359774","id":"PMC_30359774","title":"SZT2 mutation in a boy with intellectual disability, seizures and autistic features.","date":"2018","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30359774","citation_count":11,"is_preprint":false},{"pmid":"30564332","id":"PMC_30564332","title":"Novel metabolic signatures of compound heterozygous Szt2 variants in a case of early-onset of epileptic encephalopathy.","date":"2018","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/30564332","citation_count":11,"is_preprint":false},{"pmid":"36250465","id":"PMC_36250465","title":"SZT2 maintains hematopoietic stem cell homeostasis via nutrient-mediated mTORC1 regulation.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/36250465","citation_count":10,"is_preprint":false},{"pmid":"30560016","id":"PMC_30560016","title":"Identification of a rare homozygous SZT2 variant due to uniparental disomy in a patient with a neurodevelopmental disorder.","date":"2018","source":"Intractable & rare diseases research","url":"https://pubmed.ncbi.nlm.nih.gov/30560016","citation_count":10,"is_preprint":false},{"pmid":"35773235","id":"PMC_35773235","title":"mTORC1 functional assay reveals SZT2 loss-of-function variants and a founder in-frame deletion.","date":"2022","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35773235","citation_count":9,"is_preprint":false},{"pmid":"39572656","id":"PMC_39572656","title":"A novel hypoxia-induced lncRNA, SZT2-AS1, boosts HCC progression by mediating HIF heterodimerization and histone trimethylation under a hypoxic microenvironment.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/39572656","citation_count":9,"is_preprint":false},{"pmid":"34685691","id":"PMC_34685691","title":"The SZT2 Interactome Unravels New Functions of the KICSTOR Complex.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34685691","citation_count":9,"is_preprint":false},{"pmid":"33681650","id":"PMC_33681650","title":"A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant.","date":"2021","source":"Epilepsia open","url":"https://pubmed.ncbi.nlm.nih.gov/33681650","citation_count":6,"is_preprint":false},{"pmid":"32723703","id":"PMC_32723703","title":"Biallelic SZT2 variants in a child with developmental and epileptic encephalopathy.","date":"2020","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/32723703","citation_count":4,"is_preprint":false},{"pmid":"37760843","id":"PMC_37760843","title":"Insight into Genetic Mutations of SZT2: Is It a Syndrome?","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37760843","citation_count":3,"is_preprint":false},{"pmid":"36361881","id":"PMC_36361881","title":"Induced Pluripotent Stem Cell (iPSC) Lines from a Family with Resistant Epileptic Encephalopathy Caused by Compound Heterozygous Mutations in SZT2 Gene.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36361881","citation_count":3,"is_preprint":false},{"pmid":"35352205","id":"PMC_35352205","title":"Genetic analysis of developmental and epileptic encephalopathy caused by novel biallelic SZT2 gene mutations in three Chinese Han infants: a case series and literature review.","date":"2022","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35352205","citation_count":2,"is_preprint":false},{"pmid":"38134649","id":"PMC_38134649","title":"Clinical phenotype and genetic characteristics of SZT2 related diseases: A case report and literature review.","date":"2023","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/38134649","citation_count":1,"is_preprint":false},{"pmid":"36531768","id":"PMC_36531768","title":"The Dysfunctional Gangway: SZT2-associated Epilepsy with Thick Corpus Callosum.","date":"2021","source":"Journal of pediatric neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36531768","citation_count":1,"is_preprint":false},{"pmid":"41535455","id":"PMC_41535455","title":"Brain organoid models of SZT2-related disease reveal an overproduction of outer radial glial cells through mTORC1 activation.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41535455","citation_count":0,"is_preprint":false},{"pmid":"41357819","id":"PMC_41357819","title":"Novel SZT2::MAST2 Fusion Detected in Salivary Duct Carcinoma.","date":"2025","source":"Case reports in pathology","url":"https://pubmed.ncbi.nlm.nih.gov/41357819","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14044,"output_tokens":2062,"usd":0.036531},"stage2":{"model":"claude-opus-4-6","input_tokens":5333,"output_tokens":2202,"usd":0.122573},"total_usd":0.159104,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"SZT2 recruits a fraction of mammalian GATOR1 and GATOR2 to form a SZT2-orchestrated GATOR (SOG) complex; the interaction of SZT2 with GATOR1 and GATOR2 is synergistic, and an intact SOG complex is required for lysosomal localization of the complex and GATOR/SESN-dependent nutrient sensing and mTORC1 regulation.\",\n      \"method\": \"Co-immunoprecipitation, lysosomal fractionation, genetic rescue experiments (DEPDC5 overexpression, lysosome-targeted WDR59/SESN2), mouse knockout model with neonatal lethality phenotype\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including Co-IP, fractionation, in vivo mouse KO, and genetic rescue; highly cited foundational study\",\n      \"pmids\": [\"28199315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SZT2 deficiency results in constitutive mTORC1 signalling under nutrient-deprived conditions in cells, and failure to inactivate mTORC1 during fasting in vivo, demonstrating SZT2 is required for mTORC1 downregulation upon nutrient deprivation.\",\n      \"method\": \"Mouse knockout (neonatal lethality), cell-based mTORC1 activity assays under nutrient deprivation, genetic rescue with DEPDC5/GATOR2 components\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and in vivo phenotype, replicated in multiple experimental systems, highly cited\",\n      \"pmids\": [\"28199315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Biallelic loss-of-function SZT2 mutations in patient-derived lymphoblastoid cell lines cause constitutive hyperactivation of mTORC1 (increased S6K and S6 phosphorylation) under amino acid starvation, and constitutive lysosomal localization of mTOR, confirming the loss-of-function mechanism in human patient cells.\",\n      \"method\": \"Patient-derived lymphoblastoid cell lines, phosphorylation assays (S6K, S6), immunofluorescence for lysosomal mTOR localization under amino acid starvation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal methods (biochemical phosphorylation + lysosomal localization imaging) in patient-derived cells; single lab\",\n      \"pmids\": [\"31430354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Systematic interactome analysis of SZT2 identified interaction partners including mTORC1 and AMPK signaling components, autophagy regulators (selective autophagy receptors), ciliogenesis regulators, and neurogenesis-related proteins; SZT2 KO cells show increased mTORC1 signaling (reversible by Rapamycin/Torin) and elevated autophagic components independent of physiological conditions.\",\n      \"method\": \"Mass spectrometry-based interactome analysis under catabolic and anabolic conditions, SZT2 KO cell lines with mTORC1 activity measurement, Rapamycin/Torin pharmacological rescue\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — MS interactome plus KO phenotype rescue; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"34685691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SZT2 is required for hematopoietic stem cell (HSC) homeostasis via nutrient-mediated mTORC1 regulation; loss of SZT2 decreases HSC reserve and impairs repopulating capacity, and combined loss of SZT2 and TSC1 produces a synergistic ~10-fold increase in mTORC1 activity and ~100-fold increase in ROS, rapidly depleting HSCs.\",\n      \"method\": \"HSC-specific conditional KO mice, bone marrow transplantation repopulation assay, mTORC1 activity measurement, ROS quantification, double KO (SZT2 + TSC1) genetic epistasis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined cellular phenotype, genetic epistasis with TSC1, multiple orthogonal readouts in vivo\",\n      \"pmids\": [\"36250465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A recurrent in-frame deletion SZT2 p.Val1984del is a loss-of-function variant in the mTORC1 signaling pathway, identified as a founder variant in individuals of Ashkenazi Jewish ancestry, using a functional mTORC1 assay to reclassify variants of uncertain significance.\",\n      \"method\": \"Cell-based mTORC1 functional assay for SZT2 variants, haplotype analysis for founder effect determination\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay directly measuring mTORC1 activity for specific variant; single lab\",\n      \"pmids\": [\"35773235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"SZT2 dysfunction in human brain organoids causes overproduction of outer radial glial cells (oRGCs) in the SVZ-like layer and increased upper-layer neurons, through elevated mTORC1 activity in the SVZ, suggesting SZT2-mediated mTORC1 regulation controls cortical expansion and underlies macrocephaly.\",\n      \"method\": \"Patient-derived iPSC brain organoids, immunostaining for oRGC and neuron markers, mTORC1 activity measurement in SVZ region of organoids\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human brain organoid model with cellular phenotype and mTORC1 mechanistic link; single lab, novel approach\",\n      \"pmids\": [\"41535455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SZT2 variants in a patient with early-onset epileptic encephalopathy impair mitochondrial energy metabolism, providing evidence for a pathogenic molecular mechanism involving mitochondrial dysfunction.\",\n      \"method\": \"Case study with metabolic/mitochondrial functional analyses in patient cells\",\n      \"journal\": \"Clinical case reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single patient case, single lab, limited mechanistic detail on how SZT2 affects mitochondrial function\",\n      \"pmids\": [\"30564332\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SZT2 is a metazoan-specific scaffolding protein that assembles GATOR1, GATOR2, and SESN proteins into a SOG (SZT2-orchestrated GATOR) complex at the lysosome, where it functions as an essential upstream regulator of the amino acid-sensing branch of mTORC1 signaling by promoting lysosomal localization of GATOR complexes and enabling SESN-dependent GDI activity toward RAG GTPases, such that SZT2 loss causes constitutive mTORC1 hyperactivation under nutrient deprivation, with downstream consequences including impaired autophagy, excess outer radial glia production, and hematopoietic stem cell depletion.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SZT2 is a large scaffolding protein that orchestrates amino acid sensing upstream of mTORC1 by assembling GATOR1, GATOR2, and SESN proteins into a lysosome-associated SOG (SZT2-orchestrated GATOR) complex, thereby enabling nutrient-dependent mTORC1 inactivation [PMID:28199315]. Loss of SZT2 causes constitutive mTORC1 hyperactivation under nutrient deprivation, leading to impaired hematopoietic stem cell homeostasis with depleted HSC reserves and synergistic ROS elevation when combined with TSC1 loss [PMID:36250465], and to excess outer radial glia production and cortical expansion in human brain organoids [PMID:41535455]. Biallelic loss-of-function mutations in SZT2, including a recurrent founder variant in Ashkenazi Jewish individuals, cause early-onset epileptic encephalopathy with macrocephaly [PMID:35773235, PMID:31430354].\",\n  \"teleology\": [\n    {\n      \"year\": 2017,\n      \"claim\": \"Establishing how SZT2 connects to mTORC1 signaling resolved the question of its molecular function: SZT2 nucleates a SOG complex by synergistically binding GATOR1 and GATOR2, recruiting them to the lysosome where they mediate SESN-dependent nutrient sensing and mTORC1 inhibition upon amino acid deprivation.\",\n      \"evidence\": \"Co-immunoprecipitation, lysosomal fractionation, genetic rescue (DEPDC5 overexpression, lysosome-targeted WDR59/SESN2), and neonatal-lethal mouse KO\",\n      \"pmids\": [\"28199315\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for SZT2's synergistic bridging of GATOR1 and GATOR2 is unknown\",\n        \"Whether SZT2 directly binds RAG GTPases or solely acts through GATOR/SESN remains unresolved\",\n        \"Lysosomal targeting determinants within SZT2 are not mapped\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A case linking SZT2 variants to mitochondrial energy defects raised the question of whether SZT2 has mTORC1-independent roles in mitochondrial metabolism.\",\n      \"evidence\": \"Single patient case study with metabolic/mitochondrial functional analyses in patient cells\",\n      \"pmids\": [\"30564332\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single patient without independent replication or mechanistic dissection of how SZT2 affects mitochondria\",\n        \"Whether the mitochondrial phenotype is secondary to chronic mTORC1 hyperactivation is untested\",\n        \"No mitochondrial interaction partners of SZT2 are identified\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Validation in human patient-derived cells confirmed that biallelic SZT2 loss-of-function mutations produce constitutive mTORC1 activity and mTOR mis-localization to lysosomes during amino acid starvation, translating the mouse findings to human disease.\",\n      \"evidence\": \"Patient-derived lymphoblastoid cell lines with phosphorylation assays (S6K, S6) and immunofluorescence for lysosomal mTOR\",\n      \"pmids\": [\"31430354\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Only lymphoblastoid cells examined; neuronal cell types not tested\",\n        \"Downstream consequences of constitutive mTORC1 in patient cells (e.g., autophagy, protein synthesis) not characterized\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Systematic interactome mapping expanded the SZT2 interaction network beyond GATOR to include autophagy receptors and ciliogenesis regulators, and showed that SZT2 KO elevates autophagic components irrespective of metabolic state.\",\n      \"evidence\": \"Mass spectrometry-based interactome under catabolic and anabolic conditions; SZT2 KO cell lines with Rapamycin/Torin rescue\",\n      \"pmids\": [\"34685691\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct physical interactions with autophagy receptors and ciliogenesis regulators await reciprocal validation\",\n        \"Whether autophagy dysregulation is mTORC1-dependent or an independent SZT2 function is not resolved\",\n        \"Functional relevance of ciliogenesis interactors remains untested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that SZT2 loss depletes HSCs and synergizes with TSC1 loss to massively elevate mTORC1 and ROS established SZT2 as operating in a nutrient-sensing axis parallel to TSC for stem cell maintenance.\",\n      \"evidence\": \"HSC-specific conditional KO mice, bone marrow transplantation, genetic epistasis with TSC1 double KO, ROS quantification\",\n      \"pmids\": [\"36250465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether mTORC1-independent mechanisms contribute to HSC depletion is unknown\",\n        \"ROS source (mitochondrial vs. other) upon SZT2/TSC1 double loss is not identified\",\n        \"Whether rapamycin rescues the HSC phenotype in vivo was not reported\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Functional classification of a recurrent SZT2 founder variant (p.Val1984del) as loss-of-function in the mTORC1 pathway provided a direct genotype-to-mechanism link for clinical variant interpretation.\",\n      \"evidence\": \"Cell-based mTORC1 functional assay for SZT2 variants, haplotype analysis in Ashkenazi Jewish cohort\",\n      \"pmids\": [\"35773235\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural consequence of Val1984 deletion on SOG complex assembly is not characterized\",\n        \"Functional assay validated for limited number of variants\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Brain organoid modeling revealed that SZT2 dysfunction drives overproduction of outer radial glia through elevated SVZ mTORC1, providing a cellular mechanism for the macrocephaly seen in patients.\",\n      \"evidence\": \"Patient-derived iPSC brain organoids with immunostaining for oRGC/neuron markers and regional mTORC1 activity measurement\",\n      \"pmids\": [\"41535455\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether mTORC1 inhibition rescues the oRGC phenotype in organoids was not shown\",\n        \"In vivo validation in animal models of cortical expansion is lacking\",\n        \"Cell-type-specific SZT2 expression in developing human cortex is not characterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural architecture of SZT2, its precise lysosomal targeting mechanism, and whether it has mTORC1-independent functions in autophagy, ciliogenesis, or mitochondrial metabolism remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural or cryo-EM model of SZT2 or the SOG complex exists\",\n        \"mTORC1-independent roles suggested by interactome data are functionally unvalidated\",\n        \"Tissue-specific requirements for SZT2 beyond brain and hematopoietic system are unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 4]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\n      \"SOG (SZT2-orchestrated GATOR) complex\"\n    ],\n    \"partners\": [\n      \"DEPDC5\",\n      \"WDR59\",\n      \"SESN2\",\n      \"TSC1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}